Mike Wenger, Vice President of Patient Engagement, joins the Talking HealthTech Podcast to discuss the superpowers of clinical trial data. Listen to the podcast:
Salem Oaks’ Improbable Developments podcast focuses on the triumphs, defeats and lessons learned during the drug development process. In this episode, Kevin Freiert interviews Mike
As seen on TranspariMED blog – Posted Sept. 14, 2020 – Original Article Sept. 14, 2020 | The US Food and Drug Administration has dashed patient
As seen on Choose New Jersey – Posted Aug. 26, 2020 – Original Article Aug. 26, 2020 | New Jersey has been a leader in the
Awards program celebrates unstoppable entrepreneurswhose ambitions transform society JERSEY CITY, NJ, Aug. 25, 2020 – Ernst & Young LLP (EY US) has announced that TrialScope
Mike Wenger, Vice President of Patient Engagement, joins ERT’s Trial Better Podcast to discuss what motivates patients to participate in clinical trials, how the industry
As seen on BioSpace.com – Posted Aug. 14, 2020 – Original Article Aug. 14, 2020 | Russia surprised the world Tuesday when the government of that
New Partnership Reflects Moderna’s Commitment to Transparency Jersey City, NJ, July 22, 2020 — TrialScope, the global leader in clinical trial disclosure and transparency management
Chris Venezia to Leverage His Expertise in Healthcare Technology JERSEY CITY, NJ – July 9, 2020 –TrialScope, the global leader in clinical trial transparency, has
Copyright © 2022 Pharma Intelligence UK Limited
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is Suite 1, 3rd Floor, 11 – 12 St. James’s Square, London, England, SW1Y 4LB. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group
